Welcome to our dedicated page for IVEDA SOLUTIONS SEC filings (Ticker: IVDAW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Iveda Solutions, Inc. filings document registration statements, material-event reports and capital-structure disclosures for an operating company focused on AI video surveillance, video search and IoT smart city technologies. The record includes disclosures covering operating and financial results, material agreements, securities registration matters, and the company’s publicly traded common stock purchase warrants.
Regulatory filings also address governance and security-structure topics, including the company’s reverse stock split and related warrant adjustments, as well as Nasdaq continued-listing compliance matters reported on Form 8-K. These documents describe the formal terms of capital actions, offering-related securities disclosures, listing-rule notices and risk factors associated with the company’s public reporting status.
Iveda Solutions reported Q1 2026 revenue of $1.49 million, up slightly from $1.47 million a year earlier, driven mainly by higher Taiwan government project sales. Gross profit rose to $0.50 million, improving margin as cost of revenue fell. The company still posted a net loss of $0.53 million, narrower than the prior-year loss of $0.79 million, and used $0.9 million of cash in operations.
During the quarter Iveda raised net proceeds of about $1.6 million through a February 2026 equity offering, doubling common shares outstanding to 11.6 million and ending the period with $5.7 million in cash. Management concluded this cash should fund the operating plan for at least 12 months, though the company continues to carry an accumulated deficit and relies heavily on a few large Taiwan customers. Internal control over financial reporting and disclosure controls were assessed as not effective due to material weaknesses, which management is working to remediate.
Iveda Solutions reported Q1 2026 revenue of $1.49 million, up slightly from $1.47 million a year earlier, driven mainly by higher Taiwan government project sales. Gross profit rose to $0.50 million, improving margin as cost of revenue fell. The company still posted a net loss of $0.53 million, narrower than the prior-year loss of $0.79 million, and used $0.9 million of cash in operations.
During the quarter Iveda raised net proceeds of about $1.6 million through a February 2026 equity offering, doubling common shares outstanding to 11.6 million and ending the period with $5.7 million in cash. Management concluded this cash should fund the operating plan for at least 12 months, though the company continues to carry an accumulated deficit and relies heavily on a few large Taiwan customers. Internal control over financial reporting and disclosure controls were assessed as not effective due to material weaknesses, which management is working to remediate.
Iveda Solutions disclosure of beneficial ownership by Iroquois Capital Management, Richard Abbe and Kimberly Page. The filing reports each Reporting Person as beneficially owning 585,068 shares of Common Stock, reflecting shares issuable upon exercise of warrants that are subject to 4.99% Beneficial Ownership Blockers. The Form 10-K shows 11,139,740 shares outstanding as of March 15, 2026, and the warrants described are exercisable for up to 1,000,000 and 428,572 shares respectively but cannot be exercised beyond the 4.99% limit.
Iveda Solutions disclosure of beneficial ownership by Iroquois Capital Management, Richard Abbe and Kimberly Page. The filing reports each Reporting Person as beneficially owning 585,068 shares of Common Stock, reflecting shares issuable upon exercise of warrants that are subject to 4.99% Beneficial Ownership Blockers. The Form 10-K shows 11,139,740 shares outstanding as of March 15, 2026, and the warrants described are exercisable for up to 1,000,000 and 428,572 shares respectively but cannot be exercised beyond the 4.99% limit.
Iveda Solutions, Inc., now a Delaware corporation listed on Nasdaq, reports continued operating losses while positioning itself as an AI-driven smart city and IoT platform provider. For the year ended December 31, 2025, it recorded a net loss of about $3.2 million, following a $4.0 million loss in 2024, and has accumulated losses of roughly $56 million.
The company depends heavily on its Taiwan subsidiary, which generated 85% of 2025 revenue and 87% of 2024 revenue, and on a small number of large customers; four customers made up 63% of 2025 revenue. Iveda offers AI video analytics (IvedaAI), IoT platforms (Cerebro), smart power solutions, smart poles, drones, health and elder-care devices, and industrial monitoring tools.
As of March 15, 2026, Iveda had 11,139,740 shares of common stock outstanding and significant U.S. net operating loss carryforwards of about $40.0 million federal and $11.0 million state. The company highlights risks from ongoing losses, reliance on key personnel, geopolitical uncertainty around Taiwan, cybersecurity gaps, and potential Nasdaq listing compliance issues.
Iveda Solutions, Inc., now a Delaware corporation listed on Nasdaq, reports continued operating losses while positioning itself as an AI-driven smart city and IoT platform provider. For the year ended December 31, 2025, it recorded a net loss of about $3.2 million, following a $4.0 million loss in 2024, and has accumulated losses of roughly $56 million.
The company depends heavily on its Taiwan subsidiary, which generated 85% of 2025 revenue and 87% of 2024 revenue, and on a small number of large customers; four customers made up 63% of 2025 revenue. Iveda offers AI video analytics (IvedaAI), IoT platforms (Cerebro), smart power solutions, smart poles, drones, health and elder-care devices, and industrial monitoring tools.
As of March 15, 2026, Iveda had 11,139,740 shares of common stock outstanding and significant U.S. net operating loss carryforwards of about $40.0 million federal and $11.0 million state. The company highlights risks from ongoing losses, reliance on key personnel, geopolitical uncertainty around Taiwan, cybersecurity gaps, and potential Nasdaq listing compliance issues.
Iveda Solutions, Inc. has been notified by Nasdaq that its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing.
The company has 180 calendar days, until September 2, 2026, to regain compliance. Nasdaq will deem the requirement met if the closing bid price is at least $1 for a minimum of ten consecutive business days during this period. If compliance is not restored or other listing rules are breached, Nasdaq may move to delist the shares, although Iveda could appeal any delisting determination to a Nasdaq Hearings Panel.
Iveda Solutions, Inc. has been notified by Nasdaq that its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing.
The company has 180 calendar days, until September 2, 2026, to regain compliance. Nasdaq will deem the requirement met if the closing bid price is at least $1 for a minimum of ten consecutive business days during this period. If compliance is not restored or other listing rules are breached, Nasdaq may move to delist the shares, although Iveda could appeal any delisting determination to a Nasdaq Hearings Panel.
Iveda Solutions director Robert Gillen reported offsetting option transactions tied to an option repricing. He was granted 100,000 stock options on an "acquire" transaction and disposed of 100,000 options back to the issuer on a separate "disposition to issuer" transaction, leaving 128,599 options reported as held afterward.
According to a board-approved repricing on February 23, 2026, his options were reset to an exercise price of $0.29 per share while all other terms remained unchanged. The company states these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions director Robert Gillen reported offsetting option transactions tied to an option repricing. He was granted 100,000 stock options on an "acquire" transaction and disposed of 100,000 options back to the issuer on a separate "disposition to issuer" transaction, leaving 128,599 options reported as held afterward.
According to a board-approved repricing on February 23, 2026, his options were reset to an exercise price of $0.29 per share while all other terms remained unchanged. The company states these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions Chief Financial Officer Robert J. Brilon reported changes to his stock options in a paired, non-cash transaction. He was granted 125,000 options and disposed of 125,000 options, both recorded as “Options (Right to Buy).” Following these transactions, he holds 152,503 derivative securities directly.
The company’s board approved an option repricing on February 23, 2026, resetting the exercise price of his options to $0.29 per share. The filing states that all other option terms remain unchanged and that the repricing was exempt under specific Exchange Act rules.
Iveda Solutions Chief Financial Officer Robert J. Brilon reported changes to his stock options in a paired, non-cash transaction. He was granted 125,000 options and disposed of 125,000 options, both recorded as “Options (Right to Buy).” Following these transactions, he holds 152,503 derivative securities directly.
The company’s board approved an option repricing on February 23, 2026, resetting the exercise price of his options to $0.29 per share. The filing states that all other option terms remain unchanged and that the repricing was exempt under specific Exchange Act rules.
Iveda Solutions director Franco Alejandro reported an option repricing and related award. On February 23, 2026, the board approved a repricing of his options to an exercise price of $0.29 per share, with all other terms unchanged. This involved an acquisition of 25,000 options and a corresponding disposition of 25,000 options to the issuer, both recorded at a transaction price of $0.00 per option. Following these transactions, Alejandro directly held 53,130 options to acquire Iveda Solutions stock. The company notes these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions director Franco Alejandro reported an option repricing and related award. On February 23, 2026, the board approved a repricing of his options to an exercise price of $0.29 per share, with all other terms unchanged. This involved an acquisition of 25,000 options and a corresponding disposition of 25,000 options to the issuer, both recorded at a transaction price of $0.00 per option. Following these transactions, Alejandro directly held 53,130 options to acquire Iveda Solutions stock. The company notes these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions, Inc. reported that Chief Executive Officer David H. Ly had his stock options repriced by the board. On February 23, 2026, options covering 175,000 shares were granted or awarded, and a separate 175,000-option position was disposed of back to the issuer. According to the disclosure, the repricing set the exercise price at $0.29 per share, while all other option terms remained unchanged. After these offsetting derivative transactions, Ly directly held options to acquire 216,096 shares.
Iveda Solutions, Inc. reported that Chief Executive Officer David H. Ly had his stock options repriced by the board. On February 23, 2026, options covering 175,000 shares were granted or awarded, and a separate 175,000-option position was disposed of back to the issuer. According to the disclosure, the repricing set the exercise price at $0.29 per share, while all other option terms remained unchanged. After these offsetting derivative transactions, Ly directly held options to acquire 216,096 shares.
Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.
Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.
Iveda Solutions reporting persons Lind Global Fund III LP, Lind Global Partners III LLC and Jeff Easton disclose beneficial ownership of 1,158,920 shares, representing 9.99% of common stock as of 02/11/2026. The holdings consist of 857,143 shares of common stock and 1,714,286 warrants, but conversion of the warrants is contractually limited so the aggregate beneficial ownership has been capped at 1,158,920 shares.
The filing states that Lind Global Partners III LLC may be deemed to have sole voting and dispositive power for the partnership's shares and that Jeff Easton, as managing member, may be deemed to have sole voting and dispositive power. The filing includes a joint filing agreement and is signed on 02/19/2026.
Iveda Solutions reporting persons Lind Global Fund III LP, Lind Global Partners III LLC and Jeff Easton disclose beneficial ownership of 1,158,920 shares, representing 9.99% of common stock as of 02/11/2026. The holdings consist of 857,143 shares of common stock and 1,714,286 warrants, but conversion of the warrants is contractually limited so the aggregate beneficial ownership has been capped at 1,158,920 shares.
The filing states that Lind Global Partners III LLC may be deemed to have sole voting and dispositive power for the partnership's shares and that Jeff Easton, as managing member, may be deemed to have sole voting and dispositive power. The filing includes a joint filing agreement and is signed on 02/19/2026.